TriSalus Life Sciences Inc
NASDAQ:TLSI
Income Statement
Earnings Waterfall
TriSalus Life Sciences Inc
Revenue
|
18.5m
USD
|
Cost of Revenue
|
-2.6m
USD
|
Gross Profit
|
15.9m
USD
|
Operating Expenses
|
-70.1m
USD
|
Operating Income
|
-54.2m
USD
|
Other Expenses
|
-9.1m
USD
|
Net Income
|
-63.3m
USD
|
Income Statement
TriSalus Life Sciences Inc
Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
5
N/A
|
10
+113%
|
19
+89%
|
|
Gross Profit | ||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(3)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
4
N/A
|
8
+120%
|
16
+88%
|
|
Operating Income | ||||||||||
Operating Expenses |
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(18)
|
(41)
|
(70)
|
|
Selling, General & Administrative |
(3)
|
0
|
(2)
|
(2)
|
(3)
|
(3)
|
(11)
|
(24)
|
(41)
|
|
Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
(7)
|
(16)
|
(30)
|
|
Other Operating Expenses |
0
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(3)
N/A
|
(3)
-12%
|
(3)
+14%
|
(3)
+13%
|
(3)
-9%
|
(3)
-6%
|
(14)
-382%
|
(32)
-128%
|
(54)
-69%
|
|
Pre-Tax Income | ||||||||||
Interest Income Expense |
0
|
0
|
0
|
1
|
3
|
3
|
(1)
|
(2)
|
(4)
|
|
Total Other Income |
8
|
11
|
13
|
10
|
6
|
3
|
1
|
18
|
(1)
|
|
Pre-Tax Income |
5
N/A
|
8
+67%
|
10
+25%
|
9
-10%
|
6
-32%
|
3
-53%
|
(14)
N/A
|
(16)
-16%
|
(59)
-277%
|
|
Net Income | ||||||||||
Tax Provision |
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
Income from Continuing Operations |
5
|
8
|
10
|
9
|
6
|
2
|
(14)
|
(16)
|
(59)
|
|
Net Income (Common) |
5
N/A
|
8
+67%
|
10
+25%
|
9
-12%
|
6
-37%
|
2
-59%
|
(16)
N/A
|
(19)
-15%
|
(63)
-241%
|
|
EPS (Diluted) |
0.15
N/A
|
0.25
+67%
|
0.32
+28%
|
0.28
-13%
|
0.19
-32%
|
0.27
+42%
|
-0.61
N/A
|
-0.7
-15%
|
-2.05
-193%
|